Investigating National Solutions for Personalised Iodine-131 Radiation Exposure
NCT04391244 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2023-08-18
Summary
This is a single-arm non-interventional prospective observational study to perform quantitative I-131 imaging and patient-specific dosimetry for patients undergoing radioiodine treatment.
Conditions
- Differentiated Thyroid Cancer
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Kate Newbold · Consultant Clinical Oncologist
-
Glenn Flux · Head of Radioisotope Physics
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-17
- Primary Completion
- 2024-03-31
- Completion
- 2025-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
NCT04974671 ·Status: RECRUITING ·Phase: PHASE2
-
RISI in the Treatment of Recurrent Chest Wall Malignancies After EBRT
NCT04077710 ·Status: UNKNOWN
-
Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer
NCT01812486 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.
NCT01124409 ·Status: UNKNOWN ·Phase: PHASE3
-
SBRT or TACE for Advanced HCC
NCT03338647 ·Status: UNKNOWN ·Phase: PHASE3
-
Radioimmunotherapy With 131I-L19SIP in Patients With Cancer
NCT01242943 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma
NCT02795195 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus
NCT02752126 ·Status: COMPLETED ·Phase: NA
-
Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer
NCT04974346 ·Status: RECRUITING ·Phase: PHASE3
-
131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)
NCT01124812 ·Status: TERMINATED ·Phase: PHASE1
-
Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer
NCT04452032 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy
NCT03416686 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System
NCT00026871 ·Status: COMPLETED ·Phase: PHASE1
-
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT
NCT04081428 ·Status: ACTIVE_NOT_RECRUITING
-
Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma
NCT05733910 ·Status: RECRUITING ·Phase: NA
-
Intra-Operative Electron Boost and Hypofractionated Whole-Breast Irradiation During Breast-conserving Treatment (BCT)
NCT01343459 ·Status: COMPLETED ·Phase: NA
-
Detection of Circulating Biomarkers of Immunogenic Cell Death
NCT02921854 ·Status: COMPLETED ·Phase: NA
-
Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers
NCT04242459 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy
NCT04848909 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma
NCT00014326 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)
NCT02484339 ·Status: UNKNOWN ·Phase: PHASE2
-
Moderate Hypofractionated Radiotherapy for Lung Cancer
NCT03833193 ·Status: UNKNOWN ·Phase: NA
-
Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer
NCT02313298 ·Status: UNKNOWN ·Phase: PHASE2
-
Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease
NCT04462276 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers
NCT02068313 ·Status: UNKNOWN